Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical–Biological Entity?Alessia Campagna, Roberto Latagliata, Anna Lina Piccioni et al.|Journal of Clinical Medicine|2022Cited by 4
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity?Daniela De Benedittis, Roberto Latagliata, Luana Fianchi et al.|Blood|2018Cited by 2
CO-OCCURRENCE OF JAK2/CALR-POSITIVE MYELOPROLIFERATIVE DISORDER AND BCR-ABL-POSITIVE CHRONIC MYELOGENOUS LEUKAEMIA TREATED WITH COMBINATION OF TYROSINE KINASE INHIBITORS AND RUXOLITINIB.Katia Paciaroni, Tommaso Caravita di Toritto, Selenia Campagna et al.|Mediterranean Journal of Hematology and Infectious Diseases|2025Cited by 0